Sunday, June 13, 2021

LATEST ARTICLES

Pharma

Kite’s Tecartus® Demonstrates High Response Rate in Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

Life Sciences Times - 0
SANTA MONICA, Calif.-- Kite, a Gilead Company (Nasdaq: GILD), announced today results from the primary analysis of ZUMA-3, a global, multicenter, single-arm, open-label Phase...
Read more
People on the Move

Janux Therapeutics Appoints Dr. Wayne Godfrey as Chief Medical Officer

Life Sciences Times - 0
SAN DIEGO-- Janux Therapeutics, a biopharmaceutical company developing novel T cell engager immunotherapies, today announced the appointment of Wayne Godfrey, M.D., as Chief Medical...
Read more
Venture Capital

venBio Raises $550 Million Venture Capital Fund Focused on Life Sciences

Life Sciences Times - 0
SAN FRANCISCO-- venBio today announced the closing of venBio Global Strategic Fund IV, LP (“venBio Fund IV”), its fourth life sciences venture capital fund,...
Read more
Venture Capital

Bayer Acquires Noria and PSMA Therapeutics to Expand Pipeline in Prostate Cancer

Life Sciences Times - 0
WHIPPANY, N.J.-- Bayer today announced that it has entered into an agreement to acquire Noria Therapeutics Inc. (Noria) and PSMA Therapeutics Inc. Through this...
Read more
Venture Capital

Blackstone Has Acquired Desotec

Life Sciences Times - 0
CHICAGO-- Lincoln International, a global investment banking advisory firm, has advised Blackstone on the acquisition of Desotec. Based in Roeselare, Belgium, Desotec’s mission is to...
Read more
Life Sciences

Harvard Licenses Technology to Obatala Sciences to Advance Discovery in Obesity, Diabetes, and Cancer

Life Sciences Times - 0
CAMBRIDGE, Mass. & NEW ORLEANS-- Harvard University has granted an exclusive license to biotechnology company Obatala Sciences to commercialize innovations that enable the study...
Read more
Pharma

Cytovale Begins Enrollment in FDA 510(k) Clinical Validation Study of IntelliSep Rapid Sepsis Test

Life Sciences Times - 0
SAN FRANCISCO-- Cytovale, a medical diagnostics company focused on providing a faster, more insightful way to diagnose fast-moving and immune-mediated diseases, today announced the...
Read more
Venture Capital

Nayya Raises $37 Million in Series B Growth Capital, co-led by SVB Capital and ICONIQ Growth

Life Sciences Times - 0
NEW YORK-- Nayya, a leading insurance benefits experience and healthcare management platform, today announced that it has raised $37M in Series B financing, co-led...
Read more
Venture Capital

Oxford Finance Provides $24 Million Credit Facility to Lantern Group

Life Sciences Times - 0
ALEXANDRIA, Va. -- Oxford Finance LLC (“Oxford”), a leading specialty finance firm providing senior debt to healthcare services and life sciences companies worldwide, today...
Read more
People on the Move

Inspira Health Appoints Warren E. Moore, FACHE as the New Executive Vice President, Chief Operating Officer

Life Sciences Times - 0
MULLICA HILL, N.J.-- Inspira Health today announced the appointment of Warren E. Moore, FACHE, to Executive Vice President, Chief Operating Officer, effective immediately. Moore...
Read more
1234...59Page 3 of 59

Most Popular

Load more

Recent Comments

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv